Idelalisib

Hepatotoxicity: case report

    Reactions Weekly volume 1840, page216(2021)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    US$ 49.95

    Tax calculation will be finalised during checkout.

    Reference

    1. Hanlon A, et al. Managing toxicities of phosphatidylinositol-3-kinase (PI3K) inhibitors. Hematology: the Education Program of the American Society of Hematology 2020: 346-356, No. 1, 4 Dec 2020. Available from: URL: http://doi.org/10.1182/HEMATOLOGY.2020000119

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Idelalisib. Reactions Weekly 1840, 216 (2021). https://doi.org/10.1007/s40278-021-90359-1

    Download citation